Indaptus Therapeutics is trading 7.17% lower at $2.13, with no specific company announcement identified to explain the October 1 move.
- The pullback extends declines of 13.37% on September 29 and 14.55% on September 28; shares closed at $2.30 on September 30.
- Reuters reported the 10-year Treasury yield reached 5.306%, its highest since mid-June 2007. Major indices in the supplied market context were down less than 0.5%, and the evidence does not establish a clear macro cause.